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ORIGINAL ARTICLE 
Postantibiotic effect of meropenem in Combination 
with gentamicin or sparfloxacin on Gram-positive and 
Gram-negative organisms 
A n n a  Ferraral, Conceiciio Dos Santos2 and Monica Cimbro’ 
‘Cattedra dl Chemioterapia, Universiti d~ Pavia, and 21RCCS ‘Policlinico S. Matteo’, Pavia, Italy 
Objective: To determine the postantibiotic effect (PAE) on some Gram-positive and Gram-negative strains induced by 
meropenem in combination with sparfloxacin and gentamicin. 
Methods: The determinations of the minimum inhibitory concentrations (MICs) and of the PAE!; were carried out on 
two isolates each of Staphylococcus aureus, Enterococcus faecalis, Klebsiella pneurnoniae, Enterobacter cloacae, 
Serratia rnarcescens and Pseudornonas aeruginosa with meropenem, gentamicin and sparfloxacin. The PAEs of 
meropenem plus gentamicin or sparfloxacin, at 0.5 and 5 MIC, were evaluated, after an exposure time of 1.5 h, by the 
viable count method. 
Results: Combination of meropenem with gentamicin, a t  5 MIC, significantly enhanced the PAE for enterococci, which 
reached values about 1 h greater than the sum of the PAEs of the two drugs (synergistic eflect). Combination of 
meropenem with sparfloxacin, at 5 MIC, produced a distinct enhancement of the PAE for enteroclxci (roughly additive 
effect). Both combinations, meropenem plus gentamicin and meropenem plus sparfloxacin, at 5 IMIC, gave PAE values 
that were a little greater than the highest value obtained with the most active antibiotic for S. aurcrus and I? aeruginosa, 
and were consistently similar to those of the most single active antibiotic for Enterobacteriaceae (indifferent effect). 
Conclusions: The longer PAE of meropenem in combination with gentamicin or sparfloxacin, in comparison to that of 
singly tested antibiotics, could have some implications for the timing of doses during therapy with antimicrobial 
corn binations. 
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INTRODUCTION 
The persistent suppression of bacterial growth after 
brief exposure to antimicrobial agents is called the 
postantibiotic effect (PAE). Generally antibiotics that 
are inhibitors of protein synthesis produce a PAE with 
both Gram-positive and Gram-negative bacteria, while 
p-lactams induce this effect with Gram-positive cocci 
but do not seem to do so with Gram-negative bacilli. 
Only penems and carbapenems have been shown to 
produce a quite long PAE with Pseudomonas aeruginosa 
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[l-31. On these bases, it seemed interesting to 
determine the possible effect on the PAE with some 
‘difficult organisms’, including Gram-positive and 
Gram-negative strains, of interactions between a very 
active carbapenem, meropenem, and other anti- 
microbial agents with different mechanisms of action. 
Drugs studied in combination with meropenem were 
gentamicin and sparfloxacin, a new fluoroquinolone 
possessing higher in vitro activity against Gram-positive 
bacteria when compared with less recent derivatives 
[4,51. 
MATERIALS AND METHODS 
Bacterial strains 
Assays were carried out on two strains each of the 
following species: Staphylococcus aureus, Enterococcus 
faecalis, Klebsiella pneumoniae, Enterobacter cloacae, Serratia 
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marresrens and Pseudomonas aeruginosa; two of the strains 
employed were standard strains (Enterororcur faecalis 
ATCC 29212 and I? aeruginosa ATCC 27853), and all 
the others were local clinical isolates. 
Antimicrobial agents 
The antibiotics employed were kindly provided as 
follows: meropenem (ICI-Pharma, Milan, Italy); 
sparfloxacin (Rhbne-Poulenc Rorer, Milan, Italy); 
gentamicin (Schering-Plough, Milan, Italy). Sterile 
stock solutions of the antibiotics were prepared in 
accordance with the instructions of the manufacturers; 
dilutions were made in appropriate medium on the day 
on which the experiments were performed. 
Susceptibility tests 
Minimum inhibitory concentrations (MICs) were 
determined in Mueller-Hinton broth by a microtiter 
dilution technique, using a final inoculum of approxi- 
mately 10"-1O6 colony-forming units (CFU)/mL. The 
trays were incubated at 37°C for 18-24 h. The MIC 
was defined as the lowest concentration of antibiotic 
giving complete inhibition of visible growth. 
Determination of the PAE 
Exponentially growing bacteria in Mueller-Hinton 
broth were adjusted to a concentration of 107-10s CFU/ 
mL. Antibiotics or combinations of antibiotics were 
added to culture broth at concentrations equal to 
0.5 MIC and 5 MIC for the tested strains. After 
incubation of the samples at 37°C for 1.5 h in a shaking 
water-bath, drugs were removed by dilution of 
the cultures in antibiotic-&ee medium. Control cultures, 
not exposed to antibiotics, were subjected to the same 
procedure. In the case of Enterobacteriaceae, the 
antibiotics (mainly at 5 MIC), depending on the rate of 
lulling, were removed by washing three times; the pellet 
was resuspended in an adequate volume of fresh 
medium in order to obtain a suspension of 104-105 
viable post-exposure CFU/mL. Both exposed and 
control cultures were then reincubated at  37OC in a 
shaking water-bath; the number of viable organisms/ 
mL was determined at time 0, after drug removal and 
hourly throughout the 8 hours. The PAE was defined 
as the difference in time required by test and control 
cultures for a 1 log increase in colony count. PAE 
synergism was defined as the PAE induced by an 
antiniicrobial combination being at least 1 h longer 
than the sum of the PAEs for individual drugs, and 
addition as the combination PAE being roughly similar 
to the mathematical sun1 of the individual PAEs. 
Indifference was defined as the combination PAE being 
no different from the longest of the individual PAEs, 
and antagonism as the combination PAE being at least 
1 h less than the longest of the individual PAEs [6]. All 
experiments were done in triplicate. 
RESULTS 
All strains were susceptible to the tested antibiotics. 
Table 1 shows the PAEs of meropenem and gentamicin 
used singly or in combination. PAEs ranged from 0.7 
to 1.45 h for meropenem and from 0.85 to 1.6 h for 
gentamicin on Gram-positive cocci, at  concentrations 
equal to 0.5 MIC. The combination of the two anti- 
biotics at  0.5 MIC produced PAEs generally a little 
longer than those obtained with the single antibiotics 
(PAE range: 1.3-2.25 h). The PAE was commonly over 
1.5 h (1.5-2 h) for both meropenem and gentamicin at 
5 MIC, with the exception of Enterororcusfaeralis strains, 
with which the PAE of gentamicin was a little shorter 
(about 1 h). When meropenem and gentamicin were 
combined at 5 MIC, the PAE was about 1 h greater 
than the sum of the PAEs of the two drugs only with 
Enterocorrus faeralis strains (3,5 and 4 h) (a synergistic 
effect), while values just a little over those of the most 
active antibiotic were observed with Staphylororrus 
aureus strains (2 and 2.8 h). Less favorable interactions 
were obtained with Enterobacteriaceae: the PAEs of 
meropenem with K. pneumoniae,  Entevobacter cloacae and 
Serratia marcesrens, both at  0.5 and 5 MIC, were 
irrelevant or even negative (range: -0.3-0.2 h). 
Gentamicin exhibited very low PAE values (0.1-0.4 h) 
at 0.5 MIC with the same strains, but decisively greater 
values at 5 MIC (1.1-2.0 h); the combination of the 
drugs at both 0.5 and 5 MIC showed a PAE that 
generally represents the value of the most active 
antibiotic, gentamicin. 
More prolonged PAEs were induced by mero- 
penem and gentamicin with I? aeruginosa isolates when 
they were tested at  0.5 MIC (0.5 and 0.9 h, and 1.25 
and 1.5 h, respectively) and at 5 MIC (1.25 and 1.5 h, 
and 1.75 and 2.2 h, respectively). For the combination 
of the two drugs, an enhancement of PAE was observed 
at 5 MIC (2.4 and 3.15 h) while at 0.5 MIC, values 
equal to those of the most active antibiotic were 
obtained (1.35 and 1.5 h). 
The PAEs of meropenem and sparfloxacin 
used singly or in association are shown in Table 2. 
Sparfloxacin at 0.5 MIC produced a PAE of about 1 h 
with Staphylococrus uweus, while it produced very short 
PAEs (0.1 and 0.5 h) with Enterococcus faecalis. Its 
association with meropenem did not produce any 
advantage with either species. Sparfloxacin at  5 MIC 
produced a high PAE with Staphylococcus aureus, about 
3 h, but a lower one with Enterocorrus faeralis, about 
1 h. The combination of sparfloxacin with meropenem 
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at 5 MIC produced a PAE of 4 h with Staphylococcus 
aureus. However, this value does not represent any 
additive effect; the PAEs for Enterococcus faecalis were 
expressive of a roughly additive effect (about 2.4 h). 
The PAEs of sparfloxacin at 0.5 MIC ranged from 
0.15 to 0.65 h with Enterobacteriaceae, while at 
5 MIC the PAE values were decisively longer (1.65- 
2.6 h). Neither at 0.5 MIC nor at 5 MIC did the 
combination of sparfloxacin with meropenem exhibit 
any advantage, giving PAE values (0.25-0.9 h and 
1.65-2.6 h, respectively) consistently similar to those of 
the most active antibiotic, sparfloxacin. 
The PAE of sparfloxacin was about 0.6 h at 
0.5 MIC with I? aeruginosa and decisively prolonged at 
5 MIC, about 1.7 h. At both concentrations, the PAEs 
observed for the combination of sparfloxacin with 
meropenem, about 0.7 and 2 h at 0.5 and 5MIC 
respectively, never reached the sum of the PAEs of the 
single antibiotics. 
DISCUSSION 
A great number of studies carried out over the last 15 
years have demonstrated that nearly all antimicrobials 
are able to produce a PAE with a wide variety of 
bacteria [6,7]. An exception to this rule is represented 
by the p-lactam antibiotics, which induce irrelevant or 
even negative PAE values with Gram-negative rods; 
Table 1 In vitro PAEs of meropenem and gentamicin alone and in combination (mean valueskSD) 
PAE (h) 
Meropenem Gentamicin Mei-openem+ Gentamicin 
Organism 0.5 MIC 5 MIC 0.5 MIC 5 MIC 0.5 MIC 5 MIC 
Staphylococcus aureus 22 0.80f0.09 1.9020.13 1.60f0.15 2.0020.09 2.00:t0.18 2.8020.13 
Staphylococcus aurens 23 0.70f0.13 1.7520.13 1.OOf 0.09 1.7520.18 1.30:C0.18 2.00f0.17 
Enterococcus faecalis 1.10f0.05 1.50-CO.10 1.0020.09 1.2520.10 1.75f0.18 3.5020.18 
ATCC 29212 
Enterococcusfaecalis 24 1.45f0.18 1.7520.09 0.85k0.09 1.0020.09 2.25:t0.18 4.0020.23 
K. pneumoniae 6 -0.20?0.05 0.0020.13 0.3020.09 1.60k0.18 0.45.20.09 1.60f0.09 
K. pneumoniae 7 -0.10?0.17 O.OOf0.09 0.1020.05 1.20k0.10 0.40.20.05 1.20f0.13 
Enterobacter cloacae 11 -0.2520.05 0.20f0.09 0.15 20. 13 1.85f0.22 0.30 t0.13 2.0020.09 
Enterobacter cloacae 12 -0.10f0.13 O.lOfO.10 0.10f0.09 2.0020.18 0.20.tO.09 2.10f0.10 
Serratia marcescens 62 -0.3020.09 -0.20f0.05 0.4020.18 1.1020.10 0.50t0.13 1.3020. 13 
Serratia marcescens 64 -0.2020.05 -0.1OfO.18 0 . 1 0 ~ 0 . 1 0  1,2520.10 0.10C0.13 1.50f0.09 
I? aeruginosa 0.5020.13 1.50f0.13 1.50f0.13 2.2020.17 1.50t0.09 3.15f0.15 
ATCC 27853 
l? aeruginosa 229 0.90f0.09 1.2520.13 1.25 +O. 13 1.75f0.09 1.35 20.09 2.40f0.09 
Table 2 In vitro PAEs of meropenem and sparfloxacin alone and in combination (mean valueskSD) 
PAE (h) 
Organirm 
Meropenem Sparfloxacin Melopenem+ Sparfloxacin 
0.5 MIC 5 MIC 0.5 MIC 5 MIC 0.5 MIC 5 MIC 
Staphylococcus aureus 22 
Staphylococcus aureus 23 
Enterococcns faecalis 
ATCC 29212 
Enterococcusfaecalis 24 
K. pneumoniae 6 
K. pneumoniae 7 
Enterobacter cloacae 11 
Enterobacter cloacae 12 
Serratia marcescens 62 
Serratia marcescens 64 
l? aeruginosa 
ATCC 27853 
l? aerupinosa 229 
0.80f0.09 
0.70f0.13 
1.10+-0.05 
1.4520.18 
- 0.202 0.05 
-0.10f0.17 
-0.25f0.05 
-0.lOk0.13 
-0.30f0.09 
- 0.202 0.05 
0.50f0.13 
0.9020.09 
1.9020. 13 
1.75f0.13 
1.5020.10 
1.7520.09 
0.00f0.13 
0.0020.09 
0.20f0.09 
O.lOfO.10 
-0.2020.05 
-0.1OfO.18 
1.50f0.13 
1.2520.13 
0.9020.09 
1.202 0.10 
0.1020.10 
0.5020.13 
0.3520.05 
0.65k0.09 
0.3520.05 
0.1520.13 
0.20f0.09 
0.3020.09 
0.7020.13 
0.6020.09 
3.0020.18 
3.25k0.22 
1.1020.10 
1.0020.09 
1.65f0.13 
2.6020.17 
2.6020.22 
1.7520.18 
1.9520.18 
2.15f0.17 
1.6020.09 
1.75k0.09 
1.25 20.13 
1.4020.17 
l.lOtO.10 
1.50 r0.09 
0.50+0.13 
0.90t0.09 
0.40f0.18 
0.45k0.09 
0.4020.18 
0.25 k0.09 
0.70f0.13 
0.75f0.10 
4.0020.23 
4.00k0.23 
2.3020.18 
2.4520.17 
1.6520.13 
2.60k0.18 
2.6020.22 
1.7520.13 
1.95f0.18 
2.1520.17 
1.90f0.18 
2.00k0.17 
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only the newer carbapenems, imipenem and mero- 
penem, among 0-lactams, have been reported to 
induce considerable PAE values, mainly with I? 
aeruginosa [1,2]. It is well known that the duration of 
the PAE is dependent on both the type of antibiotic 
and the target organism studied. In addition, other 
parameters, e.g. time of exposure and antimicrobial 
concentrations, may heavily influence this value. 
Moreover, different methodologies recently employed 
in assessing the PAE have produced some conflicting 
results [S-lo]. It has been shown that the PAEs of 
carbapenems are highly method dependent [8] with a 
consistent underestimation when the viable count 
method is adopted instead of others such as bio- 
luminescence or morphologic techniques. Recent 
reports have shown decreased susceptibility to 
carbapenems of clinical isolates of I? aeruginosa [I 1,121: 
this resistance is conferred by the altered permeability 
of the outer membrane, due to the loss of D2 porin, 
and by the expression of chromosomal 0-lactamase. Of  
more concern is the report of a plasmid-mediated 
carbapenemase leading to resistance in I? aeruginosa 
[13,14]. These observations could imply that over- 
coming the resistance to meropenem by using it in 
combination with other antibiotics could be of value. 
Our results on meropenem PAE values, obtained 
by the conventional viable count method, reflect 
those of other investigators who employed the same 
procedure [1,8]. Meropenem at 5 MIC produced, in 
our experience, a significant PAE with l? aeruginosa 
(about 1.5 h), just a little shorter than that obtained 
with Enterococcus faecalis and Staphylococcus aureus (about 
1.7 h), while no PAE was observed with the Entero- 
bacteriaceae included in this study (K .  pneumoniae, 
Enterobacter cloacae, Serratia marcescetis). The PAE 
produced by sparfloxacin at 5 MIC was particularly 
pronounced with Staphylococcus aureus ( 2 3  h), a little 
shorter with the examined Gram-negative organisms 
(from 1.6 to 2.6 h) and decisively shorter with entero- 
cocci (1 h). Gentamicin at 5 MIC induced quite 
homogeneous PAE values, ranging from 1 to 2 h, with 
all Gram-positive and Gram-negative bacteria. 
Little information is available about PAEs induced 
by antimicrobial combinations [15-171. In our experi- 
ence, combining meropenem with gentamicin at 
5 MIC, was found to significantly enhance PAEs with 
enterococci, with values about 1 h greater than the sum 
of the PAEs for individual drugs; this means that 
a synergistic effect was obtained. Combination of 
meropenem with sparfloxacin, at 5 MIC was found to 
produce a distinct enhancement of PAEs for entero- 
cocci that could be considered roughly additive. Both 
combinations, meropenem with gentamicin and mero- 
penem with sparfloxacin, at 5 MIC, generally produced 
PAE values that were similar to those of the most active 
antibiotic with other tested organisms; this behavior 
may be considered to be expressive of indifference. 
Prolonged PAE values achieved by the use of anti- 
microbial combinations could have important impli- 
cations for timing of the doses during therapy, with the 
advantages including a lower cost of antimicrobial 
therapy and a reduced risk of toxicity. 
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